BIOMARIN PHARMACEUTICAL INC Accounts Receivable, Allowance for Credit Loss
BIOMARIN PHARMACEUTICAL INC (BMRN) had Accounts Receivable, Allowance for Credit Loss of $969.00 thousand as of 2011-03-31, per its 10-Q filed 2011-04-29.
Discontinued › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2011-04-29
- 2011-03-31: Accounts Receivable, Allowance for Credit Loss $969.00K.
- 2010-12-31: Accounts Receivable, Allowance for Credit Loss $63.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2011-03-31 | $969.00K 10-Q · filed 2011-04-29 |
| 2010-12-31 | $63.00K 10-Q · filed 2011-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |